- Bank of America Merrill Lynch 2016 Health Care Conference on May 11 in Las Vegas
- Goldman Sachs 37th Annual Global Healthcare Conference on June 9 in Ranchos Palos Verdes, California
SAN RAFAEL, Calif., May 04, 2016 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the Bank of America Merrill Lynch 2016 Health Care Conference on May 11, 2016 at 10:00am PT/1:00pm ET, in Las Vegas and the Goldman Sachs 37th Annual Global Healthcare Conference on June 9, 2016 at 10:00am PT/1:00pm ET, in Ranchos Palos Verdes, California. To access the live webcasts, please visit the investor section of the BioMarin website, www.BMRN.com. A replay will also be archived on the site for at least one week following the event.
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of five commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.
Contacts: Investors Traci McCarty BioMarin Pharmaceutical Inc. (415) 455-7558 Media Debra Charlesworth BioMarin Pharmaceutical Inc. (415) 455-7451
Source:BioMarin Pharmaceutical Inc.